Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain mechanisms of cognitive impairment during adjuvant endocrine treatment for breast cancer
NL-OMON37354Active, not recruiting
- Sponsor
- Radboud University
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen and anastrozole in breast cancer (2 cohorts), sponsored by Radboud University. Primary endpoints: Cognitive functioning and Brain imaging parameters. Started Jun 2012; status: active, not recruiting.
02
Drugs
tamoxifenanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON37354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37354.